Ⅰ型胶原蛋白α1链高表达对三阴性乳腺癌预后的影响
该研究收集148例三阴性乳腺癌手术标本,采用RT-PCR、Western blot和免疫组化检测COL1A1及α-SMA表达,分析其与临床病理特征和预后的关系。结果显示COL1A1在TNBC组织和细胞中高表达,与肿瘤大小、TNM分期、淋巴结转移、脉管侵犯及α-SMA表达相关,且为TNBC患者生存的独立影响因素(HR=3.952,P=0.004)。
要点
- COL1A1在TNBC组织中的mRNA和蛋白表达均高于癌旁组织。
- COL1A1高表达与肿瘤大小、TNM分期、淋巴结转移、脉管侵犯及α-SMA表达相关。
- COL1A1高表达是TNBC患者生存的独立影响因素(HR=3.952,P=0.004)。
核心结论
- COL1A1在TNBC组织中高表达,是TNBC患者预后的独立影响因素。
研究设计与样本
- 收集2013至2015年新疆医科大学附属肿瘤医院TNBC手术标本148例。
- 采用实时荧光定量PCR检测COL1A1 mRNA,Western blot检测COL1A1蛋白,免疫组化检测COL1A1和α-SMA表达。
- 分析COL1A1表达与TNBC临床病理特征及预后的关系。
主要发现
- MDA-MB-231细胞中COL1A1 mRNA和蛋白表达量分别为1.696±0.486和0.550±0.088,均高于MCF-10A细胞的1.020±0.231和0.350±0.083(P=0.032,P=0.046)。
- TNBC组织中COL1A1 mRNA和蛋白表达量分别为1.632±0.598和0.733±0.068,均高于癌旁组织的1.041±0.316和0.612±0.016(P=0.003,P=0.039)。
- TNBC组织COL1A1和α-SMA高表达率分别为35.8%和56.7%,均高于癌旁组织的16.7%和30.0%(P=0.041,P=0.037)。
- COL1A1表达与肿瘤大小、TNM分期、淋巴结转移、脉管侵犯、α-SMA表达有关(均P<0.05)。
- COL1A1高表达组中位生存时间为64个月,低于低表达组的73个月(P<0.05);多因素Cox分析显示COL1A1表达是TNBC患者生存的独立影响因素(HR=3.952,P=0.004)。
临床怎么用
- COL1A1高表达提示TNBC患者预后较差,可作为预后评估的潜在生物标志物。
- COL1A1表达与α-SMA相关,提示其可能反映肿瘤微环境中的间质活化状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the expression of type Ⅰ collagen α1 chain protein (COL1A1) in triple negative breast cancer (TNBC), and its relationship with clinicopathological features and prognosis of TNBC. Methods: A total of 148 TNBC specimens were collected from the Affiliated Cancer Hospital of Xinjiang Medical University from 2013 to 2015. The mRNA expression of COL1A1 was detected by fluorescence quantitative RT-PCR and the protein expression of COL1A1 was detected by Western blot. The expression of COL1A1 and α-smooth muscle actin (α-SMA) in TNBC were detected by immunohistochemistry. The relationship between the expression of COL1A1 and clinicopathological parameters and prognosis of TNBC patients was analyzed. Results: The mRNA and protein expression of COL1A1 in MDA-MB-231 cells were 1.696±0.486 and 0.550±0.088, respectively, which were higher than those in MCF-10A cells (1.020±0.231 and 0.350±0.083, P=0.032, P=0.046). The mRNA and protein expression of COL1A1 in TNBC tissues were 1.632 ±0.598 and 0.733 ±0.068, respectively, which were higher than those in paracancerous tissues (1.041±0.316 and 0.612±0.016, P=0.003, P=0.039). The high expression rates of COL1A1 and α-SMA in TNBC tissues were 35.8% and 56.7% respectively, which were higher than those in paracancerous tissues (16.7% and 30.0%, P=0.041, P=0.037). The expression of COL1A1 was correlated with tumor size, TNM stage, lymph node metastasis, vascular invasion and α-SMA expression (all P<0.05). The median survival time in COL1A1 high expression group was 64 months, which was lower than that in low expression group (73 months, P<0.05). Multivariate analysis of Cox proportional hazard regression model showed that COL1A1 expression was an independent influencing factor for the survival of TNBC patients (HR=3.952, P=0.004). Conclusion: The high expression of COL1A1 in TNBC is an independent prognostic factor of TNBC patients. 目的: 了解Ⅰ型胶原蛋白α1链(COL1A1)在三阴性乳腺癌(TNBC)组织中的表达,探讨其与TNBC临床病理特征及患者预后的关系。 方法: 收集TNBC手术标本148例,采用实时荧光定量聚合酶链反应检测COL1A1的mRNA表达,采用Western blot法检测COL1A1的蛋白表达,采用免疫组化法检测COL1A1和α-平滑肌肌动蛋白(α-SMA)的表达状态,分析COL1A1表达状态与TNBC患者临床病理特征和预后的关系。 结果: MDA-MB-231细胞中COL1A1的mRNA和蛋白表达量分别为1.696±0.486和0.550±0.088,均高于MCF-10A细胞(分别为1.020±0.231和0.350±0.083;P=0.032,P=0.046)。TNBC组织中COL1A1的mRNA和蛋白表达量分别为1.632±0.598和0.733±0.068,均高于癌旁组织(分别为1.041±0.316和0.612±0.016;P=0.003,P=0.039)。TNBC组织COL1A1和α-SMA的高表达率分别为35.8%和56.7%,均高于癌旁组织(分别为16.7%和30.0%;P=0.041,P=0.037)。COL1A1的表达与TNBC的肿瘤大小、TNM分期、淋巴结转移、脉管侵犯、α-SMA表达有关(均P<0.05)。COL1A1高表达组患者的中位生存时间为64个月,低于低表达组(73个月,P<0.05)。Cox比例风险回归模型多因素分析显示,COL1A1表达是TNBC患者生存的独立影响因素(HR=3.952,P=0.004)。 结论: COL1A1在TNBC组织中高表达,是TNBC患者预后的独立影响因素。.
引用
- Li FF, Fan JJ, Ma BL, et al. [Effect of high expression of type Ⅰ collagen α1 chain protein on the prognosis of triple negative breast cancer]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32135646. doi:10.3760/cma.j.issn.0253-3766.2020.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。